blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0865789

EP0865789 - Pharmaceutical compositions for intranasal administration of dihydroergotamine [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.01.2006
Database last updated on 05.10.2024
Most recent event   Tooltip25.05.2007Change - lapse in a contracting state
Updated state(s): LU
published on 27.06.2007  [2007/26]
Applicant(s)For all designated states
Merkus, Franciscus Wilhelmus Henricus Maria
Grootreesdijk 26
B-2460 Kasterlee / BE
[1998/39]
Inventor(s)01 / see applicant
...
[1998/44]
Representative(s)Jump, Timothy John Simon, et al
Venner Shipley LLP
200 Aldersgate
London EC1A 4HD / GB
[N/P]
Former [1998/39]Jump, Timothy John Simon, et al
Venner Shipley & Co. 20 Little Britain
London EC1A 7DH / GB
Application number, filing date98109002.018.03.1994
[1998/39]
Priority number, dateBE1993000029726.03.1993         Original published format: BE 9300297
BE1993000029826.03.1993         Original published format: BE 9300298
BE1993000029926.03.1993         Original published format: BE 9300299
[1998/39]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0865789
Date:23.09.1998
Language:EN
[1998/39]
Type: A3 Search report 
No.:EP0865789
Date:07.01.1999
[1999/01]
Type: B1 Patent specification 
No.:EP0865789
Date:16.03.2005
Language:EN
[2005/11]
Search report(s)(Supplementary) European search report - dispatched on:EP19.11.1998
ClassificationIPC:A61K31/48, A61K47/36, A61K47/40, A61K9/00, A61K47/26, A61K47/48, A61P25/06
[2003/23]
CPC:
A61K47/26 (EP,US); A61K31/48 (EP,US); A61K31/485 (EP,US);
A61K47/40 (EP,US); A61K9/0043 (EP,US); A61P25/00 (EP);
A61P25/04 (EP); A61P25/06 (EP); A61P25/16 (EP);
A61P27/16 (EP) (-)
Former IPC [1999/01]A61K31/48, A61K47/36, A61K47/40, A61K31/485, A61K9/00, A61K47/26, A61K47/48
Former IPC [1998/39]A61K31/48, A61K9/00, A61K47/26, A61K47/48
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1998/39]
TitleGerman:Pharmazeutische Zusammensetzungen zur intranasalen Verabreichung von Dihydroergotamin[1998/39]
English:Pharmaceutical compositions for intranasal administration of dihydroergotamine[1998/39]
French:Compositions pharmaceutiques pour une administration intranasale de dihydroergotamine[1998/39]
Examination procedure01.06.1999Examination requested  [1999/30]
28.11.2000Despatch of a communication from the examining division (Time limit: M06)
07.06.2001Reply to a communication from the examining division
12.07.2004Communication of intention to grant the patent
22.11.2004Fee for grant paid
22.11.2004Fee for publishing/printing paid
Parent application(s)   TooltipEP94911944.0  / EP0689438
Opposition(s)19.12.2005No opposition filed within time limit [2006/10]
Fees paidRenewal fee
29.05.1998Renewal fee patent year 03
29.05.1998Renewal fee patent year 04
29.05.1998Renewal fee patent year 05
22.03.1999Renewal fee patent year 06
21.03.2000Renewal fee patent year 07
28.03.2001Renewal fee patent year 08
21.03.2002Renewal fee patent year 09
28.03.2003Renewal fee patent year 10
26.03.2004Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipLU18.03.2005
MC31.03.2005
[2007/26]
Former [2007/17]MC31.03.2005
LU16.05.2005
Former [2006/14]MC31.03.2005
Documents cited:Search[X]GB1592563  (SANDOZ LTD) [X] 1,2,6-10 * example 5; claims 1,11,21 *;
 [X]EP0463653  (ERBA CARLO SPA [IT]) [X] 1-5,8-10 * col.3, l.9-15; col.5, l.47; col.7, l.4-24; col.8, l.32-39 *;
 [X]US5169849  (KIECHEL JEAN-RENE [FR], et al) [X] 1,2,9,10 * col.2, l.26-62; col.5, l.13-18, l.59-62; col.8, l.38-48; claims 28 and 29 *;
 [A]  - HERMENS ET AL, "Der Einfluss von Arzneimitteln auf die Bewegung nasaler Flimmerhaare", DEUTSCHE APOTHEKER ZEITUNG, (19901101), vol. 130, no. 44, pages 2411 - 15, XP000159385 [A] 1-10 * page 2414, column 3, paragraph 1 - page 2415, paragraph 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.